Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0C0LG
|
||||
| Former ID |
DNC013297
|
||||
| Drug Name |
N-(1-(1-phenylethyl)piperidin-4-yl)-2-naphthamide
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [528639] | ||
| Formula |
C24H26N2O
|
||||
| Canonical SMILES |
CC(C1=CC=CC=C1)N2CCC(CC2)NC(=O)C3=CC4=CC=CC=C4C=C3
|
||||
| InChI |
1S/C24H26N2O/c1-18(19-7-3-2-4-8-19)26-15-13-23(14-16-26)25-24(27)22-12-11-20-9-5-6-10-21(20)17-22/h2-12,17-18,23H,13-16H2,1H3,(H,25,27)
|
||||
| InChIKey |
LVIBIBUWEMTPMC-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 2A receptor | Target Info | Inhibitor | [528639] | |
| PANTHER Pathway | 5HT2 type receptor mediated signaling pathway | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.